ArrowMark Colorado Holdings LLC

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1483859 Denver, CO

Position in NAMS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$7,179,359

-$1,128,004 QoQ

Shares Held

211,843

-18.4% QoQ

Ownership

0.177%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

#57

of 198 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ArrowMark Colorado Holdings LLC holds $294,624,620 across 32 Biotechnology names. NAMS ranks #19 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABCL	AbCellera Biologics Inc.	4,105,095	$32,224,995
2	DFTX	Definium Therapeutics, Inc.	564,069	$26,533,805
3	MAZE	Maze Therapeutics, Inc.	767,383	$22,898,708
4	TNGX	Tango Therapeutics, Inc.	708,385	$22,144,115
5	RPRX	Royalty Pharma plc	366,199	$20,532,777
6	PRAX	Praxis Precision Medicines, Inc.	46,030	$15,410,383
7	ZBIO	Zenas BioPharma, Inc.	573,318	$14,550,810
8	CGON	CG Oncology, Inc.	155,354	$11,037,901

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,179,359	211,843	-18.4%	Shares	Sole	2026-08-13
2026-03-31	$8,307,363	259,524	-12.9%	Shares	Sole	2026-05-15
2025-12-31	$10,456,541	298,077	-4.2%	Shares	Sole	2026-02-17
2025-09-30	$8,844,811	310,999	-13.3%	Shares	Sole	2025-11-14
2025-06-30	$6,494,499	358,614	-0.9%	Shares	Sole	2025-08-14
2025-03-31	$7,404,449	361,722	+4.8%	Shares	Sole	2025-05-15
2024-12-31	$8,867,733	345,048	-2.8%	Shares	Sole	2025-02-14
2024-09-30	$5,892,585	354,975	+19.5%	Shares	Sole	2024-11-14
2024-06-30	$5,708,616	297,169	+0.1%	Shares	Sole	2024-08-14
2024-03-31	$7,019,485	296,807	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.